98 related articles for article (PubMed ID: 9862521)
1. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
2. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
5. Changes in retinoblastoma gene expression during cervical cancer progression.
Salcedo M; Taja L; Utrera D; Chávez P; Hidalgo A; Pérez C; Benítez L; Castañeda C; Delgado R; Gariglio P
Int J Exp Pathol; 2002 Dec; 83(6):275-86. PubMed ID: 12657136
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
7. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S; Güllü IH
Cancer; 1999 Jun; 85(12):2668-9. PubMed ID: 10375117
[No Abstract] [Full Text] [Related]
9. Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions.
Protrka Z; Arsenijevic S; Dimitrijevic A; Mitrovic S; Stankovic V; Milosavljevic M; Kastratovic T; Djuric J
Eur J Histochem; 2011 Mar; 55(1):e8. PubMed ID: 21556123
[TBL] [Abstract][Full Text] [Related]
10. H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix.
Utrera-Barillas D; Salcedo-Vargas M; Gariglio-Vidal P; Hernández-Hernández DM; Gutiérrez-Delgado F; Benítez-Bribiesca L
Arch Med Res; 2000; 31(2):172-81. PubMed ID: 10880723
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis.
Agnantis NJ; Mahera H; Maounis N; Spandidos DA
Eur J Gynaecol Oncol; 1992; 13(4):309-15. PubMed ID: 1325346
[TBL] [Abstract][Full Text] [Related]
12. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
13. Expression of heat shock protein 70 and c-myc in cervical carcinoma.
Abd el All H; Rey A; Duvillard P
Anticancer Res; 1998; 18(3A):1533-6. PubMed ID: 9673366
[TBL] [Abstract][Full Text] [Related]
14. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
[TBL] [Abstract][Full Text] [Related]
15. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
16. c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data.
Devictor B; Bonnier P; Piana L; Andrac L; Lavaut MN; Allasia C; Charpin C
Gynecol Oncol; 1993 Jun; 49(3):284-90. PubMed ID: 8390959
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical detection of p21ras, c-myc and p53 oncoproteins in hepatocellular carcinoma and in non-neoplastic liver tissue].
Pannain VL; Bottino AC; Santos RT; Coelho HS; Ribeiro-Filho J; Alves VA
Arq Gastroenterol; 2004; 41(4):225-8. PubMed ID: 15806265
[TBL] [Abstract][Full Text] [Related]
18. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
[TBL] [Abstract][Full Text] [Related]
19. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.
Deguchi H; Hamano H; Hayashi Y
Acta Pathol Jpn; 1993; 43(7-8):413-22. PubMed ID: 8396843
[TBL] [Abstract][Full Text] [Related]
20. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
